Ling Tao
Xi'an, Shannxi, 710032, China
NCT Number: NCT05706064
Using online questionnaires, we will obtain data regarding COVID-19 infection and treatment, including incidence rate, hospitalization rate, severity of the infection, medications, mortality rate, etc, in both hospital and communities after the change of disease control policy in China.
Looking for future studies?
Notify MeAll sexes
Observational
Xi'an, Shannxi, 710032, China
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 6 months
Quickly obtain the all-cause mortality in patients with COVID-19
Time frame: 6 months
Incidence rate of COVID-19 infection
Time frame: 6 months
Any medication for COVID-19 treatment
Time frame: 6 months
Hospitalization rate due to COVID-19 infection
Time frame: 6 months
severity of the COVID-19 infection
Xijing Hospital
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05069623
COVID-19, Coronaviridae Infections
Bergen, Norway
View Trial DetailsNCT05321433
COVID-19, Coronaviridae Infections
Solna, Stockholm County, Sweden
View Trial DetailsNCT05371561
Behavior, COVID-19
Al Fayyum, Egypt
View Trial DetailsNCT05387655
BCG Vaccination Reaction, COVID-19
Nijmegen, Gelderland, Netherlands
View Trial Details